Trial Profile
Clinical Efficacy of Rifabutin in the Treatment of Serious and Life Threatening Infections Due to Mycobacterium Avium Complex, or Drug Resistant Mycobacterium Tuberculosis, or Other Drug Resistant Mycobacterium
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 May 2017
Price :
$35
*
At a glance
- Drugs Rifabutin (Primary)
- Indications Mycobacterium avium complex infections; Nontuberculous mycobacterium infections
- Focus Therapeutic Use
- 25 May 2017 New trial record